Search results

Articles (5)

Journals (0)

1-5 of 5 results for elranatamab

Sort by:

Relevance

Select all

Sort by:

Relevance

Retricted access

Review article

First published 2025-5

Engaging a New Treatment Paradigm: Elranatamab in Relapsed/Refractory Multiple Myeloma

George Saied, Zachery Halford

Annals of Pharmacotherapy

Open access

Case report

First published 2026

Progressive multifocal leukoencephalopathy associated with elranatamab therapy in relapsed/refractory multiple myeloma

Tansuhan Çetiner, Merve Çağla Bilek, Selin Arslan Kirezli [...]

Journal of Oncology Pharmacy Practice

Open access

Letter

First published 2023-10

Elrexfio™ (elranatamab-bcmm): The game-changer in treatment of multiple myeloma

Taruba Rais, Afsheen Khan, Rumaisa Riaz

Rare Tumors

Retricted access

Review article

First published 2025-5

B-Cell Maturation Antigen-Directed Immunotherapies for the Treatment of Relapsed/Refractory Multiple Myeloma: A Review of the Literature and Implications for Clinical Practice

Matthew R. Peery, Hailey Hill, Amanda Sharps [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2025

The impact of growth factor utilization on infection risk in patients receiving bispecific monoclonal antibodies

Yong jun Bae, Houry Leblebjian, Robert Redd [...]

Journal of Oncology Pharmacy Practice